confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons
on behalf of the Registrant and in the capacities and on the dates indicated:
Name Title Date
/s/    Timothy D. Cook
Chief Executive Officer and Director
(Principal Executive Officer) October 28, 2021
TIMOTHY D. COOK
/s/    Luca Maestri
Senior Vice President, Chief Financial Officer
(Principal Financial Officer) October 28, 2021
LUCA MAESTRI
/s/    Chris Kondo
Senior Director of Corporate Accounting
(Principal Accounting Officer) October 28, 2021
CHRIS KONDO
/s/    James A. Bell Director October 28, 2021
JAMES A. BELL
/s/    Al Gore Director October 28, 2021
AL GORE
/s/    Andrea Jung Director October 28, 2021
ANDREA JUNG
/s/    Arthur D. Levinson Director and Chair of the Board October 28, 2021
ARTHUR D. LEVINSON
/s/    Monica Lozano Director October 28, 2021
MONICA LOZANO
/s/    Ronald D. Sugar Director October 28, 2021
RONALD D. SUGAR
/s/    Susan L. Wagner Director October 28, 2021
SUSAN L. WAGNER
Apple Inc. | 2021 Form 10-K | 60DESCRIPTION OF THE REGISTRANT’S SECURITIES
REGISTERED PURSUANT TO SECTION 12 OF THE
SECURITIES EXCHANGE ACT OF 1934
As of September 25, 2021, Apple Inc. (“Apple” or the “Company”) had eleven classes of securities registered
under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): (i) Common Stock,
$0.00001 par value per share (“Common Stock”); (ii) 1.000% Notes due 2022 (the “2022 Notes”); (iii) 1.375% Notes
due 2024 (the “2024 Notes”); (iv) 0.000% Notes due 2025 (the “0.000% 2025 Notes”); (v) 0.875% Notes due 2025
(the “0.875% 2025 Notes”); (vi) 1.625% Notes due 2026 (the “2026 Notes”); (vii) 2.000% Notes due 2027 (the “2027
Notes”); (viii) 1.375% Notes due 2029 (the “1.375% 2029 Notes”); (ix) 3.050% Notes due 2029 (the “3.050% 2029
Notes”); (x) 0.500% Notes due 2031 (the “2031 Notes”); and (xi) 3.600% Notes due 2042 (the “2042 Notes,” and
together with the 2022 Notes, the 2024 Notes, the 0.000% 2025 Notes, the 0.875% 2025 Notes, the 2026 Notes, the
2027 Notes, the 1.375% 2029 Notes, the 3.050% 2029 Notes, and the 2031 Notes, the “Notes”). Each of the
Company’s securities registered under Section 12 of the Exchange Act are listed on The Nasdaq Stock Market LLC.
DESCRIPTION OF COMMON STOCK
The following is a description of the rights of Common Stock and related provisions of the Company’s
Restated Articles of Incorporation (the “Articles”) and Amended and Restated Bylaws (the “Bylaws”) and applicable
California law. This description is qualified in its entirety by, and should be read in conjunction with, the Articles,
Bylaws and applicable California law.
Authorized Capital Stock
The Company’s authorized capital stock consists of 50,400,000,000 shares of Common Stock.
Common Stock
Fully Paid and Nonassessable
All of the outstanding shares of the Company’s Common Stock are fully paid and nonassessable.
Voting Rights
The holders of shares of Common Stock are entitled to one vote per share on all matters to be voted on by
such holders. Holders of shares of Common Stock are not entitled to cumulative voting rights.
Except as described below or as required by law, all matters to be voted on by shareholders must be
approved by the affirmative vote of (i) a majority of the shares present or represented by proxy and voting and (ii) a majority of the shares required to constitute a quorum.
In an election of directors where the number of nominees exceeds the number of directors to be elected, the
candidates receiving the highest number of affirmative votes of the shares entitled to be voted for them up to the
